SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

LIPPS, B. V.. Sub-lethal injection of honeybee venom decreased the levels of endogenously present substances in organs of mice. J. Venom. Anim. Toxins [online]. 2002, vol.8, n.2, pp.255-268. ISSN 0104-7930.

    1 BARRAVIERA B., LOMONTE B., TARAKOWSKI A., HANSON LA., MEIRA DA. Acute-phase reactions, including cytokines, in patients bitten by Bothrops and Crotalus snakes in Brazil. J. Venom. Anim. Toxins, 1995, 1, 11-22. [ Links ]

    2 BARROS SF., FRIEDLANSKAIA I., PETRICEVICH VL., KIPNIS TL. Local inflammation, lethality and cytokine release in mice injected with Bothrops atrox venom. Med. Inflm., 1998, 7,339-46. [ Links ]

    3 BOLLINGER ME., ARREDONDO-VEGA FX., SANTISTEBAN I., SCHWARZ K., HIRSHFIELD MS., LEDERMAN HM. Brief report: hepatic dysfunction as a complication of adenosine deaminase-deficiency. N. Engl. J. Med., 1996, 334, 1367-71. [ Links ]

    4 FAGAN DL., SLAUGHTER CA., CAPRA JD., SULIVAN TJ. Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophil in vitro. J. Allergy Clin. Immunol., 1982, 70, 399-404. [ Links ]

    5 FOZARD JR., PFANNKUCH HJ., SCHUURMAN HJ. Mast cell degranulation following adenosine A3 receptor activation in rats. Eur. J. Pharmacol., 1997, 298, 293-7. [ Links ]

    6 FREDERIKSEN S. Specificity of adenosine deaminase toward adenosine and 2'-deoxyadenosine analogues. Arch. Biochem. Biophys., 1966, 113, 383-8. [ Links ]

    7 HIRSCHHORN R. Immunodeficiency disease due to deficiency of adenosine deaminase. In: OCHS HD., SMITH CIE., PUCK JM. Eds. Primary immunodeficiency disease: a molecular and genetic approach. New YorK: Oxford University Press, 1999: 121-38. [ Links ]

    8 HOFFMAN DR., WOOD DL., HUDSON P. Demonstration of IgE and IgG antibodies against venoms in the blood of victims of fatal anaphylaxis. J. Allergy Clin. Immunol., 1983, 73, 193-6. [ Links ]

    9 KEMENY DM., LESSOF MH., PATEL S., YOULTEN LJ., WILLIAMS A., LAMBOURN E. IgG and IgE antibodies after immunotherapy with bee and wasp venom. Int. Arch. allergy Appl. Immunol., 1989, 88, 247-9. [ Links ]

    10 LIPPS BV. Biological and immunological properties of nerve growth factor from snake venoms. J. Nat. Toxins, 1998, 7, 121-30. [ Links ]

    11 LIPPS BV. Detection of nerve growth factor (NGF) in venoms from diverse source: Isolation and characterization of NGF from the venom of honeybee (Apis mellifera). J. Nat. Toxins, 2000, 9, 13-9. [ Links ]

    12 LIPPS BV. Decreased levels of nerve growth factor in organs of mice as a consequence of sub-lethal injection of cobra venom. J. Nat. Toxins, 10, 2001, 283-90. [ Links ]

    13 LIPPS BV., KHAN AA. The presence of pharmacological substances myoglobin and histamine in venoms. J. Venom. Anim. Toxins, 2001, 7, 45-55. [ Links ]

    14 LIPPS BV. Sub-lethal injection of cobra venom decreases adenosine deaminase, histamine, and IgE in organs of mice. J. Venom. Anim. Toxins, 8, 2002, 60-73. [ Links ]

    15 LOMONTE B., TARKOWSKI A., HANSON LA. Host response to Bothrops asper snake venom: analysis of edema formation, inflammatory cells and cytokine release in mouse model. Inflammation, 1993, 17, 93-105. [ Links ]

    16 PETRICEVICH VL., TEIXEIRA CFP., TAMBOURGI DV., GUTIERREZ JM. Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon, 2000, 38, 1253-66. [ Links ]

    17 PONRAJ D., GOPALAKRISHNAKONE P. Establishment of an animal model for myoglobinuria by use of a myotoxin from Pseudchis australis (king cobra snake) venom in mice. Lab. Anim. Sci., 1996, 46, 393-8. [ Links ]

    18 RAHMY TR., HEMMAID KZ. Histological and histochemical alterations in the liver following intramuscular injection with sublethal dose of Egyptian cobra venom. J. Nat. Toxins, 2000, 9, 21-32. [ Links ]

    19 RAHMY TR., RAMADAN RA., FARID TM., EL-ASMAR MF. Renal lesions induced by cobra envenomation. J. Egypt. Ger. Soc. Zool., 1995, 17, 251-71. [ Links ]

    20 RAHMY TR., RAMADAN RA., FARID TM., EL-ASMAR MF. Hepatic pathogenesis due to cobra envenomation. J. Egypt. Ger. Soc. Zool., 2000, 16, 85-102. [ Links ]

    21 RASH LD., KING RG., HODSON WC. Evidence that histamine is the principal pharmacological component of venom from an Australian wolf spider (Lycosa godeffroyi). Toxicon, 1998, 36, 367-75. [ Links ]

    22 RATECH H., GRECO MA., GALLO DL., RIMOIN DL., KAMINO H., HIRCHHORN R. Pathologic findings in adenosine deaminase-deficiency severe combined immunodeficiency. Kidney, adrenal and chondro - osseous tissue alternations. Am. J. Pathol., 1985, 120, 157-69. [ Links ]

    23 REID HA. Myogloburia and sea-snake poisoning. Br. Med. J., 1961, 1, 1284-9. [ Links ]

    24 ROTHCHILD AM., ROTHCHILD Z. Liberation of pharmacologically active substances by snake venom. In: LEE CY Ed. Snake Venoms. Berlin: Springer-Verlag, 1979: 541. [ Links ]

    25 SOFER S., GUERON M., WHITE RM., LIFSHITZ M., APATE RN. Interleukin-6 release following scorpion sting in children. Toxicon, 1996, 34, 389-92. [ Links ]

    26 WU AH., LAIOS I., GREEN S., GORNET TG., WONG SS., PARMLEY L., TONNESEN AS., PLAISIER B., ORLANDO R. Immunoassays for serum and urine myoglobin: myoglobin clearance assayed as a risk factor for acute renal failure. Clin. Chem., 1994, 40, 796-802. [ Links ]

    27 ZORA JA., SWANSON MC., YUNGINGER JW. A study of the prevalence and clinical significance of venom-specific IgE. J. Allergy Clin. Immunol., 1988, 81, 77-82. [ Links ]